The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u...se research.
The framework adopts the One health approach and focuses on the role that responsible life sciences research can play in preventing and mitigating risks caused by accidents, inadvertent or deliberate misuse with the intention to cause harm to humans, nonhuman animals, plants and agriculture, and the environment.
more
Quarta Edição.
Esta quarta edição do manual se baseia no esquema de avaliação de risco apresentado na terceira edição. Uma avaliação completa, baseada em evidências e transparente dos riscos permite que as medidas de segurança sejam equilibradas com o risco real de trabalhar com agentes... biológicos, caso a caso. Isso permitirá que os países implementem políticas e práticas de biossegurança e biosseguridade laboratoriais economicamente viáveis e sustentáveis que sejam relevantes para suas circunstâncias e prioridades individuais.A necessidade de atualizar as diretrizes de biossegurança de laboratórios internacionais faz parte de uma iniciativa mais ampla para globalizar a biossegurança e enfatizar os princípios e as abordagens que são acessíveis a países que tenham ampla gama de recursos financeiros, técnicos e regulatórios
more
An overview of validation structures and responsibilities at national, regional and global levels.
This governance document supplements the global guidance document. Validation of elimination requires rigorous assessment at the national, regional and global levels of the impact and process indicato...rs and the fulfilment of the four foundational requirements for (1) data quality, (2) strong programmes, (3) laboratory quality and (4) human rights, gender equality and community engagement.
more
The GEHM series is an evidence-informed normative product of the WHO
Health and Migration Programme to inform policy-makers on migrationrelated public he...alth priorities. These reviews aim to respond to policy questions identified as priorities by summarizing the best available evidence worldwide and proposing policy considerations. By addressing data gaps on the health status of refugees and migrants, the GEHM series aims to support evidenceinformed policy-making and targeted interventions that are impactful and make a difference in the lives of these populations.
This Report, the fourth in the GEHM series reviews the available evidence on barriers to antibiotic access and appropriate use in refugees and migrants. It finds that the available evidence on refugees’ and migrants’ access to and use of antibiotics is scarce and is largely constrained to high-income contexts.
more
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding... climate, in which value for money and the efficient use of resources to fill the most critical of gaps are more relevant than ever.
more
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – cause nearly three-quarters of deaths in the world. Their drivers are social, environment...al, commercial and genetic, and their presence is global. Every year 17 million people under the age of 70 die of NCDs, and 86% of them live in low- and middle-income countries.
Users can explore the data below by country, accessing detailed information on noncommunicable diseases and their key risk factors
more
As of 25 September 2022, a cumulative number of 18 confirmed and 18 probable cases have been reported from Mubende, Kyegegwa and Kassanda districts, including 23 deaths, of which five were among confirmed cases (CFR among confirmed cases 28%). This is the first Ebola disease outbreak caused by Sudan... virus (SUDV) in Uganda since 2012.
more
Mafunzo haya ya kina ya kiwango wastani ni ya wauguzi wanaowatunza wagonjwa wanaoshukiwa au waliothibitishwa kuwa na ugonjwa wa virusi vya Ebola (EVD). Moduli hii inatoa taarifa ya uchunguzi na ukaguzi, na kuzuia maambukizi and kuthibiti, uchunguzi wa maabara, taratibu za Kituo cha Matibabu ya Ebola... (ETC), uuguzi wa wagonjwa kwenye ETC, uchunguzi wa kimatibabu.sw
more
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic..., this report reflects on the main challenges and key solutions on the road to equitable access to diagnostics and therapeutics.
This report draws from experience gained through the Access to COVID-19 Tools (ACT) Accelerator Diagnostics and Therapeutics pillars, and includes the perspectives of collaborating stakeholders (countries, civil society representatives and the private sector). Building on these findings, this report proposes sixteen recommended actions to address what have been identified as key structural challenges and specifies a potential owner for each action.
more
The WHO webpage on cholera provides an overview of the disease, its causes, and prevention strategies. Cholera is an acute diarrheal infection caused by the bacterium Vibrio cholerae, typically spread through contaminated food or water. It remains a... significant global health issue, particularly in areas with poor water and sanitation infrastructure.
more
الكوليرا هي عدوى إسهالية حادة تنتج عن تناول طعام أو ماء ملوث. توفر هذه الدورة مقدمة عامة عن الكوليرا وتستهدف الأفراد المسئولين عن الاستجابة لفاشيات المرض في حالات ا...طوارئ المعقدة أو في البيئات التي تعرضت فيها البنية التحتية البيئية الأساسية للتلف أو الدمار.
more
While COVID-19 virus continues to circulate and evolve, new variants are constantly emerging. Most of the current COVID-19 cases are driven by the circulation of the BA.5 subvariant of Omicron. The COVID-19 vaccines are being updated with Omicron variants to provide broader immunity against circulat...ing and emerging variants.
more
On September 10, 2022, the Ministry of Health (MOH) announced a cholera outbreak in Aleppo governorate with 15 laboratory confirmed cases reported between August 25 and September 9, 2022. Activities under this plan seek to address the immediate need...s stemming from this outbreak and highlight response priorities across all areas of the response and key sectors involved. This plan initially focuses on the Health, Water Sanitation and Hygiene (WASH), and Risk Communication and Community Engagement (RCCE) responses for an initial period of 90 days. The activities detailed in this plan are also within the programmatic scope of the 2022-2023 Humanitarian Response Plan (HRP).
more
Please find here the latest situation reports
Getting on track to end AIDS as a public health threat by 2030. This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration... on HIV and AIDS, which the United Nations General Assembly adopted in June 2021 and they are underpinned by the Global AIDS Strategy (2021–2026). The Strategy sets out the principles, approaches, priority action area and programmatic targets for the global HIV response
more
No rumo certo para acabar com a SIDA como ameaca à saúde pública até 2030. This new Road Map charts a way forward for country-level actions to achieve an ambitious set of HIV prevention targets by 2025. Those targets emerged from the 2021 Political Declaration on HIV and AIDS, which the United N...ations General Assembly adopted in June 2021 and they are underpinned by the Global AIDS Strategy (2021–2026). The Strategy sets out the principles, approaches, priority action area and programmatic targets for the global HIV response
more
جُدري القردة مرضٌ معدٍ مستجدٌ، يسبِّبه فيروس ينتقل إلى البشر من الحيوانات المصابة، التي تكون من القوارض في أغلب الأحيان. ويمكن أن تنتشر العدوى به إلى أشخاص آخرين، إ...ا أن انتقال العدوى من شخص إلى آخر لا يمكن أن يؤدي وحده بسهولة إلى حدوث فاشية. ولا تختلف المظاهر السريرية عن تلك التي شوهدت في الماضي مع الجدري، إلا أنها أقل وخامة. وقد تم استئصال الجدري في جميع أنحاء العالم في عام 1980، إلا أن جُدري القردة لا يزال يظهر بشكل متقطِّع في أجزاءٍ من وسط وغرب أفريقيا بالقرب من الغابات الاستوائية المطيرة. ويتراوح معدل إماتة الحالات في فاشيات جُدري القردة ما بين 1-10%، إلا أنه مع الرعاية الملائمة، يتعافى أغلب المرضى. وتوفر هذه الدورة التدريبية مقدمةً عامةً عن جُدري القردة، وهي موجهة إلى العاملين الصحيين المسؤولين عن الوقاية من مرض
more
A varíola dos macacos é uma doença infeciosa emergente causada por um vírus transmitido aos humanos por animais infetados, na sua maioria roedores. Pode ser propagado a outras pessoas, mas a transmissão de pessoa para pessoa, isoladamente, não pode facilmente sustentar um surto. A apresentaç...o clínica é semelhante à observada no passado com a varíola, mas menos grave. A varíola foi erradicada mundialmente em 1980; no entanto, a varíola dos macacos ainda ocorre esporadicamente em partes da África Central e Ocidental, perto das florestas tropicais húmidas. Normalmente, a mortalidade nos surtos da varíola dos macacos tem sido de 1 a 10%, mas com os cuidados adequados, a maioria dos doentes recupera. Este curso fornece uma introdução geral à varíola dos macacos e destina-se aos profissionais de saúde responsáveis pela prevenção e controlo da varíola dos macacos.
more
La viruela del mono es una enfermedad transmisible emergente causada por un virus que se transmite a los seres humanos a partir de animales infectados, generalmente roedores. Puede contagiarse a otras personas, pero la transmisión de persona a persona por sí sola no es capaz de mantener un brote. ...La presentación clínica es similar a la observada en el pasado con la viruela, pero menos grave. La viruela fue erradicada en el mundo en 1980; sin embargo, la viruela del mono sigue produciéndose esporádicamente en partes de África Central y Occidental, cerca de las selvas tropicales. Normalmente, la letalidad en los brotes de viruela del mono ha sido del 1 al 10%, pero con los cuidados adecuados, la mayoría de los pacientes se recupera. Este curso ofrece una introducción general a la viruela del mono y está dirigido al personal sanitario responsable de la prevención y el control de la viruela del mono.
more
manual de referencia rápida de anomalías congénitas e infecciones seleccionadas